Selected Tag: Gland Pharma
Selected Tag: Gland Pharma

Market Wrap

Benchmarks Extend Losses as West Asia Tensions, IT Selloff Weigh

An end-of-day recap of all that transpired in the Indian markets, highlighting the major price movements and the factors driving them

Dehuti Jani

June 11, 2026 at 11:40 AM IST

Article related image

Istock.com

Market Wrap

Economic Survey Lifts Equities, but Rupee Weakness Caps Gain

An end-of-day recap of all that transpired in the Indian markets, highlighting the major price movements and the factors driving them

Dehuti Jani

January 29, 2026 at 11:34 AM IST

Article related image

iStocks/AlexLMX

Gland Pharma Gets USFDA Approval for Olopatadine Ophthalmic Solution

BasisPoint Insight

January 8, 2026 at 6:44 AM IST

Most Indian Pharma Exports May Escape US Tariff, But Uncertainty Clouds Branded Generics 

US 100% tariff plan sparks confusion: if branded generics are treated as patented drugs, India is safe; if as branded imports, then some pharma exports face trouble.

Ajay Srivastava

September 26, 2025 at 7:56 AM IST

Article related image

Istock.com/moussa81

Gland Pharma Gets GMP Nod From Danish Regulator For Hyderabad Facility

BasisPoint Insight

July 14, 2025 at 9:16 AM IST

US FDA Closes Inspection Of Gland Pharma’s Vizag Sterile API Facility

BasisPoint Insight

June 25, 2025 at 11:55 AM IST

Gland Pharma Says Cenexi’s Compliance Measures Cleared By French Regulator

BasisPoint Insight

June 5, 2025 at 9:51 AM IST

Gland Pharma Gets US FDA Nod For Generic Angiotensin II

BasisPoint Insight

June 4, 2025 at 7:55 AM IST

Gland Pharma Gets USFDA Nod For Glaucoma Drug, Secures 180-Day Exclusivity

BasisPoint Insight

May 2, 2025 at 2:36 AM IST

The Bureau

Flawed Design, Poor Planning Make Extreme Heat Conditions Worse For Indian Cities
Video Thumbnail
The Foster Mother of Lodhi Garden
Image
Shyam Sundar Sharma